Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04576377
PHASE4

Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures

Sponsor: The University of Hong Kong

View on ClinicalTrials.gov

Summary

The aims of this vaccine trial are: (1) to measure humoral and selected cellular immune responses to repeated influenza vaccination with Flublok, including these responses' associations with age, birth year, and prior vaccination history; (2) to identify the characteristics of study participants who are vaccinated but still become infected with influenza virus ("vaccine failures") and participants who have poor immune responses to vaccination; and (3) to predict how influenza vaccinations and infections shape immunity.

Official title: The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE) Study - a Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

977

Start Date

2020-10-05

Completion Date

2025-12-31

Last Updated

2026-05-15

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

FluBlok

Recombinant HA quadrivalent influenza vaccine (0.5mL Flublok®, Sanofi Pasteur) containing 180μg antigen, 45μg for each influenza strain included.

OTHER

Placebo

0.5mL saline placebo.

Locations (1)

The University of Hong Kong

Hong Kong, Hong Kong